Trials / Completed
CompletedNCT00464971
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Atrophic Vaginitis: An Extension Trial
Evaluation of Safety and Efficacy of 17-Beta Estradiol in Treatment of Estrogen Deficiency-Derived Atrophic Vaginitis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 102 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- Female
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This trial was conducted in the United States of America (USA). This trial aimed to evaluate safety and efficacy of 17-beta Estradiol in the treatment of atrophic vaginitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | estradiol, 25 mcg |
Timeline
- Start date
- 1995-01-31
- Primary completion
- 1996-11-30
- Completion
- 1996-11-30
- First posted
- 2007-04-24
- Last updated
- 2017-03-01
Source: ClinicalTrials.gov record NCT00464971. Inclusion in this directory is not an endorsement.